Skip to main content
WGS logo
WGS
(NASDAQ)
GeneDx Holdings Corp.
$63.38-- (--)
Loading... - Market loading

GeneDx Holdings (WGS) Stock Price & Financial Analysis

GeneDx Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$61.68 - $64.42
52-Week High$170.87
52-Week Low$32.21
Open$61.68
Volume372.32K
Average Volume (3M)910.97K
Market Cap1.84B
Shares Outstanding29.34M
Price to Sales (P/S)4.09
Price to Book (P/B)7.12
EV/EBITDA-48.83
Revenue (TTM)442.68M
Net Income (TTM)-77.81M
Free Cash Flow (TTM)-28.65M
EPS (TTM)$-2.63
Profit Margin-17.58%
Operating Margin-14.91%
Return on Equity (ROE)-30.62%
Debt to Equity0.40
50-Day MA$55.40
200-Day MA$93.85
52-Week Change-23.29%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About GeneDx Holdings

What is the current stock price for WGS?

As of the latest trading session, WGS stock trades at $63.38. The 52-week range is $32.21–$170.87, with a day range of $61.68–$64.42.

What is the P/E ratio for WGS?

The P/E ratio (Price-to-Earnings) for WGS is shown in the Key Statistics section. This valuation metric helps compare GeneDx Holdings Corp. to industry peers.

Does WGS pay dividends?

GeneDx Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for WGS?

Based on 8 analysts, the consensus for WGS is Buy.

What is the market cap of WGS?

GeneDx Holdings's market capitalization is $1.86B, classifying it as a small-cap company. GeneDx Holdings operates in the Healthcare sector within the Diagnostics & Research industry.